Get an overview of this industry based on evidence (content), analytics, workflow, and point-of-care solutions. Also, analyze the start-ups creating innovative technologies, emerging business models, key competitors, drivers, restraints, and growth opportunities powering the future potential of this segment.
How is the increased demand for patient-specific surgeries influencing this segment? What are the changing reimbursement policies? Which are the latest leasing models, mergers and acquisitions, and joint ventures? Which initiatives are leading players adopting to accelerate the growth of surgical robotics technologies? Find out in this research.
How is the adoption of hybrid systems stimulating this segment? How is this industry segmented? What are the key growth metrics? What are the various distribution channels? Who are the key participants? How is competitive pricing opening new revenue models? Find out all about this segment in this extensive research.
Global energy prices increased significantly in the second half of 2021 and early 2022, buoyed by the recovery in the global economy. Russia’s invasion of Ukraine led to another dramatic spike in prices, although these have now retreated to near pre-invasion levels, as key OPEC producers signaled they will increase the global supply. But what could Russia’s invasion of Ukraine mean for global energy markets in the medium to long terms? What are the possible growth opportunities for companies servicing the sector?
Schedule a dialog or email us at myfrost@frost.com to connect with an industry expert at no charge. We are taking unprecedented action to make our team available to help you cut through the media and politics to get factual one-to-one guidance for the issues and opportunities that matter most to your business.
How are changing regulations and consumerization opening new avenues of growth?
Read more Request Info
How are digital solutions facilitating better outcomes and patient experience?
Read more Request Info
Explore how the emergence of new radiopharmaceuticals will boost future growth
Read more Request Info
What AI-based technologies are enhancing workflow and accuracy in this space?
Read more Request Info
Get detailed analyses on major business models, competitive landscape, and cost structure
Read more Request Info
What are the notable acquisitions and capacity expansions by leading bio-CDMOs?
Read more Request Info
What technological innovations are paving the way for novel growth opportunities?
Read more Request Info
How is the mobile deployment of imaging systems creating a surge in demand?
Read more Request InfoPhilips’ products and solutions are aligned toward achieving its North Star—Quadruple Aim in Healthcare. Philips has committed significant resources to develop strategic tools, such as its vendor-neutral HealthSuite Platform, which will significantly expand the company’s solution portfolio and market reach and diversify its revenue base.
Read more
Frost & Sullivan recently assessed the North American clinical decision support (CDS) industry, and based on its findings, recognizes Wolters Kluwer with the 2021 North America Company of the Year Award. The company delivers its solutions – UpToDate®, Lexicomp®, Emmi®, and Medi-Span® Sentri7® and POC Advisor™ – to help clinicians minimize the risk of misaligned clinical decisions.
Read more
Frost & Sullivan recently analyzed the North American Laboratory Information Systems Industry and recognizes LigoLab as the 2022 Competitive Strategy Leadership Award winner for improving the efficiency of diagnostic laboratories and transforming them into thriving businesses.
Read more
The global femtech market reached $707.6 million in 2021 and is expected to hit $1.15 billion by 2025, driven mainly by the demand from fertility, menopause and geriatric care. While the older demographic will be the largest market for this segment, the younger population is expected to drive the general health & wellness segment and embrace new technologies more enthusiastically.
As the impact of digitalization advances across all sectors, businesses are at a crucial turning point. They must optimize the returns from their existing resources while embracing new business models to create greater value for customers amid a challenging environment caused by the pandemic, geopolitical pressures and the supply chain crisis.
The post-COVID-19 pandemic recovery and other geopolitical events in 2021 have left the healthcare & life sciences industry in a remarkable position to be ready for 2022 and beyond. As healthcare consumerism continues to boom, Frost & Sullivan forecasts the global healthcare & life sciences industry to hit revenues of $2.8 trillion by 2025.
Read more
